Crossmark

Robustness of Multiple Imputation Methods for Missing Risk Factor Data from Electronic Medical Records for Observational Studies

Published Online: 2022-09-10

Published Print: 2022-12

Authors

Paul, Sanjoy K. https://orcid.org/0000-0003-0848-7194
Ling, Joanna

Samanta, Mayukh

Montvida, Olga
License Information

Text and Data Mining valid from 2022-09-10

Version of Record valid from 2022-09-10
More Information

Article History

Received: 9 May 2022

Revised: 26 July 2022

Accepted: 18 August 2022

First Online: 10 September 2022

Declarations

:

: The CEMR database contains longitudinal information for de-identified individuals. Research studies using the individual patient-level data from CEMR database are exempt from ethics approval from an institutional review board and informed consent—US Department of Health and Human Services Exemption 4 (CFR 46.101(b)(4)).

: SKP is currently a full-time employee of AstraZeneca. He has acted as a consultant and/or speaker for Novartis, GI Dynamics, Roche, AstraZeneca, Guangzhou Zhongyi Pharmaceutical and Amylin Pharmaceuticals LLC. He has received grants in support of investigator and investigator-initiated clinical studies from Merck, Novo Nordisk, AstraZeneca, Hospira, Amylin Pharmaceuticals, Sanofi-Aventis and Pfizer. JL, MS and OM have no conflict of interest to declare.

Document is current